国际生殖健康计划生育杂志201306
國際生殖健康計劃生育雜誌201306
국제생식건강계화생육잡지201306
Journal of International Reproductive Health/Family Planning
2013年
6期
427-432
,共6页
芯片分析技术%微阵列分析%生殖技术,辅助%高通量测序%植入前遗传学诊断
芯片分析技術%微陣列分析%生殖技術,輔助%高通量測序%植入前遺傳學診斷
심편분석기술%미진렬분석%생식기술,보조%고통량측서%식입전유전학진단
Microchip analytical procedures%Microarray analysis%Reproductive techniques,assisted%High-throughput sequencing%Preimplantation genetic diagnosis
基因芯片和深度测序是两大最重要的高通量检测技术,给生物学和医学研究带来巨大的变化,在功能基因组、系统生物学、药物基因组的研究和遗传疾病诊断中得到了广泛的应用。随着全基因组扩增技术的不断改良,高通量技术在辅助生殖植入前遗传学诊断(PGD)中的应用有了巨大的进展。基于微阵列技术的胚胎全染色体组非整倍体筛查及结构异常的PGD已经开始临床应用,PGD /植入前遗传学筛查(PGS)后的临床妊娠率和胚胎植入率显著提高;基于单细胞高通量测序技术的染色体非整倍体及单基因病诊断的临床试验也已见报道,并有希望在不久的将来走向临床应用。
基因芯片和深度測序是兩大最重要的高通量檢測技術,給生物學和醫學研究帶來巨大的變化,在功能基因組、繫統生物學、藥物基因組的研究和遺傳疾病診斷中得到瞭廣汎的應用。隨著全基因組擴增技術的不斷改良,高通量技術在輔助生殖植入前遺傳學診斷(PGD)中的應用有瞭巨大的進展。基于微陣列技術的胚胎全染色體組非整倍體篩查及結構異常的PGD已經開始臨床應用,PGD /植入前遺傳學篩查(PGS)後的臨床妊娠率和胚胎植入率顯著提高;基于單細胞高通量測序技術的染色體非整倍體及單基因病診斷的臨床試驗也已見報道,併有希望在不久的將來走嚮臨床應用。
기인심편화심도측서시량대최중요적고통량검측기술,급생물학화의학연구대래거대적변화,재공능기인조、계통생물학、약물기인조적연구화유전질병진단중득도료엄범적응용。수착전기인조확증기술적불단개량,고통량기술재보조생식식입전유전학진단(PGD)중적응용유료거대적진전。기우미진렬기술적배태전염색체조비정배체사사급결구이상적PGD이경개시림상응용,PGD /식입전유전학사사(PGS)후적림상임신솔화배태식입솔현저제고;기우단세포고통량측서기술적염색체비정배체급단기인병진단적림상시험야이견보도,병유희망재불구적장래주향림상응용。
Gene chips and deep sequencing,as two most important high-throughput genomics technologies, have been widely used in many areas of biomedical research,including functional genomics,systems biology, pharmacogenomics and diagnostics. With the advent of modified whole genome amplification technologies ,it has been promoted to apply the high-throughput technologies in preimplantation genetic diagnosis (PGD). Based on the microarray technology, two technologies, the whole chromosomes set screening and the PGD with chromosomal structural analysis, have been introduced into clinical practice. The clinical pregnancy and embryo implantation rate after preimplantation genetic screening (PGS) or PGD have been significantly improved. Furthermore,two new technologies based on the single cell high-throughput sequencing, the chromosomal aneuploidy detecting and the single gene disease PGD,have been reported. It is hopeful that these new technologies be applied to the clinic in the near future.